Last C$0.36 CAD
Change Today -0.06 / -14.46%
Volume 3.0K
IMM On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 11:38 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

immunotec inc (IMM) Snapshot

Open
C$0.36
Previous Close
C$0.42
Day High
C$0.36
Day Low
C$0.36
52 Week High
06/3/14 - C$0.46
52 Week Low
11/4/13 - C$0.25
Market Cap
24.5M
Average Volume 10 Days
21.1K
EPS TTM
C$0.02
Shares Outstanding
68.9M
EX-Date
--
P/E TM
17.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNOTEC INC (IMM)

Related News

No related news articles were found.

immunotec inc (IMM) Related Businessweek News

No Related Businessweek News Found

immunotec inc (IMM) Details

Immunotec Inc., a network marketing company, manufactures and sells natural health products and dietary supplements in Canada, the United States, Europe, Mexico, and other countries. The company’s principal products include Immunocal, a natural source of glutathione precursor cysteine for the maintenance of strong immune system; and Immunocal Platinum to reduce inflammation and body acidity. It also offers Pure Milk Calcium, a calcium supplement; Omega-3 + CoQ10 with Turmeric for the maintenance of heart and brain function; vitamin and mineral supplements with Chlorella; and Probiotics with Cranberry for the digestive system. In addition, the company provides Magistral, a natural liquid remedy that supports and maintains prostate health; PNT 200, a bioactive milk peptide for stress relief; Thermal Action tablets for weight-loss; and K-21 for energy production, growth, and nourishment functions. Further, it offers Xtra Sharp, an energy tonic; E-motion, an energy booster for maintaining physical stimulation and mental focus; concentrated cherry juice, skin perfecting cream, and toothpaste; and MiForm Transformation and Maintenance Kits, as well as meal replacement shakes and bars. The company sells its products through a network marketing system comprising independent distributors. Immunotec Inc. is headquartered in Vaudreuil-Dorion, Canada.

immunotec inc (IMM) Top Compensated Officers

Chief Executive Officer, Director and Chairma...
Total Annual Compensation: C$166.2K
Chief Financial Officer and Vice President
Total Annual Compensation: C$229.3K
Chief Operating Officer and Vice President
Total Annual Compensation: C$198.1K
Vice-President of Research & Development
Total Annual Compensation: C$192.3K
Compensation as of Fiscal Year 2013.

immunotec inc (IMM) Key Developments

Immunotec Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended April 30, 2014

Immunotec Inc. announced unaudited consolidated earnings results for the second quarter and six months ended April 30, 2014. For the quarter, the company reported revenue of CAD 19,062,000 against CAD 12,630,000 a year ago period. Operating income was CAD 1,229,000 against CAD 556,000 a year ago. Net profit was CAD 770,000 or CAD 0.01 per basic and diluted share against CAD 659,000 or CAD 0.01 per basic and diluted share a year ago. These period-over-period improvements are primarily the result of revenue growth in Mexico and the United States. Adjusted EBITDA was CAD 1,420,000 against CAD 932,000 a year ago. For the six months, the company reported revenue of CAD 35,218,000 against CAD 24,810,000 a year ago period. Operating income was CAD 1,800,000 against CAD 1,158,000 a year ago. Net profit was CAD 1,529,000 or CAD 0.02 per basic and diluted share against CAD 1,187,000 or CAD 0.02 per basic and diluted share a year ago. Adjusted EBITDA was CAD 2,181,000 against CAD 1,760,000 a year ago.

Immunotec Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended January 31, 2014

Immunotec Inc. announced unaudited consolidated earnings results for the first quarter ended January 31, 2014. For the quarter, revenues were CAD 16,156,000, operating income was CAD 572,000 and net profit was CAD 759,000 or CAD 0.01 per basic and diluted share against revenues were CAD 12,179,000, operating income was CAD 603,000 and net profit was CAD 528,000 or CAD 0.01 per basic and diluted share for the same period a year ago. Adjusted EBITDA was CAD 763,000 against CAD 828,000 for the same period a year ago.

Immunotec Inc. Announces Executive Changes

Immunotec Inc. announced that Mr. Daniel Audet, Vice-President, Marketing, will be leaving Immunotec effective March 11, 2014 to pursue new opportunities. To enable smooth operational functioning and an orderly evaluation of organizational needs, Ms. Kim Hayes will serve as Senior Director of Marketing with accountability for all marketing functions. Ms. Hayes will report to JP Trottier, Vice-President of Field Development.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMM:CN C$0.36 CAD -0.06

IMM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMM.
View Industry Companies
 

Industry Analysis

IMM

Industry Average

Valuation IMM Industry Range
Price/Earnings 17.1x
Price/Sales 0.4x
Price/Book 2.0x
Price/Cash Flow 12.0x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOTEC INC, please visit www.immunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.